BIOLOGIC/DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD)
Kevzara is a prescription medication approved by the Food and Drug Administration (FDA) to treat adults with moderately to severely active rheumatoid arthritis. Kevzara may be prescribed in cases when other disease-modifying antirheumatic drugs (DMARDs) have been ineffective or caused side effects that cannot be tolerated. Kevzara is also known by its drug name, Sarilumab.
Kevzara is considered a biologic DMARD. Kevzara is a genetically engineered protein. Kevzara is believed to work by inhibiting interleukin (IL)-6, a chemical messenger involved in autoimmune attacks. Kevzara prevents IL-6 from signaling the immune system to attack the tissues.
How do I take it?
Kevzara is administered once every two weeks by subcutaneous injection.
Kevzara is available as a prefilled, single-use syringe or pen.
The FDA-approved label for Kevzara lists common side effects including upper respiratory infections, urinary tract infections, and injection site reactions.
Rare but serious side effects listed for Kevzara include serious infections, blood disorders, gastrointestinal perforation, and hypersensitivity reactions.
For more details about this treatment, visit:
Kevzara.com – Sanofi